Predisposition Biomarkers Market: Overview

  • Biomarkers have received vast clinical and scientific value and interest in the practice of medicine. They are potentially useful along the whole spectrum of the disease process. Biomarkers can be used for screening and risk assessment. Furthermore, they can be used to determine and monitor the recurrent diseases.
  • Advances in genomics, proteomics, and molecular pathology have generated many candidate biomarkers with potential clinical value. Genetic predisposition, also known as genetic susceptibility, is characterized as an increased likelihood of developing a health disorder based on the presence of a particular biomarker.  For instance, a patient with increased susceptibility to breast cancer is determined by the presence of the BRCA1 and/or BRCA2 genes.
  • Genetic testing is considered for disease risk when an individual has a family or personal history that indicates an inherited risk for a particular health condition. Genetic markers, in particular, play a vital role in understanding disease risk. This is now widely accepted that a majority of complex disorders, including cancers, arise not from single gene-variants or single exposures; but rather from the interplay between an individual’s genetic susceptibilities and their personal exposures.

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure of Predisposition Biomarkers Market Report

Key Drivers of Global Predisposition Biomarkers Market

  • Advancements in diagnostic techniques, rise in burden of diseases, and need for novel diagnostic techniques are expected to drive the global predisposition biomarkers market
  • Fast and progressive growth in the field of pharmaceutical and biotechnology drives the development of innovative and powerful sensing technique for detection and process optimization of biomolecules at very low concentrations. Moreover, increase in prevalence of chronic diseases such as cancer and cardiac disorders has boosted the growth of predisposition biomarkers. 
  • According to the World Health Organization (WHO), cancer accounted for 8.8 million deaths in 2015. Globally, 1 in 6 deaths is due to cancer. As per the WHO, an estimated 17.9 million people died from cardiovascular diseases in 2016, representing 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke. Hence, rise in prevalence of cancer and other chronic diseases and need for personalized medicine are expected to drive the predisposition biomarkers market during the forecast period. 
  • Increase in technological advances in instruments and biomarker detection techniques are some of the factors anticipated to drive the global predisposition biomarkers market during the forecast period 

North America to Hold Major Share of Global Predisposition Biomarkers Market

  • North America is projected to account for a prominent share of the global market during the forecast period. Increase in research & development activities in the field of diagnostics; adoption of advanced testing techniques and presence of major players in life sciences industry; large number of research institutes; and growing need for new and improved therapies to address medical conditions are expected to fuel the growth of the market in the region.
  • Economic growth in India, China, Brazil, Mexico, and other countries in Asia and Latin America has improved the health care infrastructure and accessibility to innovative products and health care services. Moreover, rise in incidence of non-communicable and chronic diseases along with aging population and increase in disposable income are expected to drive the predisposition biomarkers market.

Looking for Regional Analysis or Competitive Landscape in Predisposition Biomarkers Market, Ask for a Customized Report

Key Players Operating in Global Predisposition Biomarkers Market

Major players operating in the global predisposition biomarkers market are:

  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories
  • Danaher Corporation
  • bioMérieux
  • QIAGEN
  • Siemens Healthineers
  • Myriad Genetics 

Global Predisposition Biomarkers Market: Research Scope 

Global Predisposition Biomarkers Market, by Application

  • Oncology
  • Metabolic Diseases
  • Neurological Diseases
  • Cardiac Diseases
  • Others

 Global Predisposition Biomarkers Market, by End-user

  • Hospitals
  • Contract Research Organizations
  • Academic Research Institutes
  • Others

 Global Predisposition Biomarkers Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Predisposition Biomarkers Market

Pre Book